-transparent.png){kind=logo}
Plasmapheresis was used as the sole treatment modality in 4 patients with systemic lupus erythematosus. The presence of circulating immune complexes in this group of patients was not predictive of response to plasmapheresis. Lymphocytotoxic antibody levels fell in 3 of the 4 patients, and no consistent changes in T lymphocytes, T lymphocyte subsets, complement, or immunoglobulin levels were observed. Followup during the subsequent 6 months showed deterioration in clinical and laboratory parameters in all 4 patients, and the protocol was discontinued. Plasmapheresis without concomitant therapy may be detrimental to certain patients with systemic lupus erythematosus.
Related Publications
R Schlansky, and
R J DeHoratius, and
T Pincus, and
K S Tung
June 1977,
British medical journal,
R Schlansky, and
R J DeHoratius, and
T Pincus, and
K S Tung
February 1991,
The Journal of rheumatology,
R Schlansky, and
R J DeHoratius, and
T Pincus, and
K S Tung
July 1990,
Zhonghua nei ke za zhi,
R Schlansky, and
R J DeHoratius, and
T Pincus, and
K S Tung
September 1982,
The International journal of artificial organs,
R Schlansky, and
R J DeHoratius, and
T Pincus, and
K S Tung
January 1981,
The Netherlands journal of medicine,
R Schlansky, and
R J DeHoratius, and
T Pincus, and
K S Tung
January 1988,
Annals of internal medicine,
R Schlansky, and
R J DeHoratius, and
T Pincus, and
K S Tung
March 1998,
Arthritis and rheumatism,
R Schlansky, and
R J DeHoratius, and
T Pincus, and
K S Tung
January 1982,
Progress in clinical and biological research,
R Schlansky, and
R J DeHoratius, and
T Pincus, and
K S Tung
April 1979,
Dermatologische Monatschrift,
R Schlansky, and
R J DeHoratius, and
T Pincus, and
K S Tung
June 2012,
Internal medicine journal,
